| Patients | |
---|---|---|
n | % | |
Adults who received 1 L treatment for NSCLC | 1257 | – |
Excluded patients | 254 | 100 |
 NSCLC not advanced or metastatic at diagnosis | 151 | 59.4 |
 Treatment started outside of study period | 47 | 18.5 |
 ECOG PS score missing | 15 | 5.9 |
 Randomized trial participant | 9 | 3.5 |
 Response data missing | 8 | 3.1 |
 Never received treatment | 7 | 2.8 |
 Duplicate patient | 5 | 2.0 |
 Age missing | 4 | 1.6 |
 Sex missing | 3 | 1.2 |
 Not NSCLC | 2 | 0.8 |
 Date of death or last hospital follow-up missing | 1 | 0.4 |
 Histological diagnosis missing | 1 | 0.4 |
 Diagnosis date unknown | 1 | 0.4 |
Met inclusion criteria | 1003 | – |